These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24239186)

  • 21. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
    Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
    ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.
    Fauber BP; Gobbi A; Robarge K; Zhou A; Barnard A; Cao J; Deng Y; Eidenschenk C; Everett C; Ganguli A; Hawkins J; Johnson AR; La H; Norman M; Salmon G; Summerhill S; Ouyang W; Tang W; Wong H
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2907-12. PubMed ID: 26048793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallography-guided discovery of carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators: insights into different protein behaviors with "short" and "long" inverse agonists.
    Yu MC; Yang F; Ding XY; Sun NN; Jiang ZY; Huang YF; Yan YR; Zhu C; Xie Q; Chen ZF; Guo SQ; Jiang HL; Chen KX; Luo C; Luo XM; Chen SJ; Wang YH
    Acta Pharmacol Sin; 2021 Sep; 42(9):1524-1534. PubMed ID: 33239687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional induction of P-glycoprotein efflux pump by phenyl benzenesulfonamides: Synthesis and biological evaluation of T0901317 analogs.
    Padala AK; Wani A; Vishwakarma RA; Kumar A; Bharate SB
    Eur J Med Chem; 2016 Oct; 122():744-755. PubMed ID: 27497733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LXR-mediated inhibition of CD4+ T helper cells.
    Solt LA; Kamenecka TM; Burris TP
    PLoS One; 2012; 7(9):e46615. PubMed ID: 23029557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design.
    Narjes F; Xue Y; von Berg S; Malmberg J; Llinas A; Olsson RI; Jirholt J; Grindebacke H; Leffler A; Hossain N; Lepistö M; Thunberg L; Leek H; Aagaard A; McPheat J; Hansson EL; Bäck E; Tångefjord S; Chen R; Xiong Y; Hongbin G; Hansson TG
    J Med Chem; 2018 Sep; 61(17):7796-7813. PubMed ID: 30095900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel quinazolinedione derivatives as RORγt inverse agonist.
    Fukase Y; Sato A; Tomata Y; Ochida A; Kono M; Yonemori K; Koga K; Okui T; Yamasaki M; Fujitani Y; Nakagawa H; Koyama R; Nakayama M; Skene R; Sang BC; Hoffman I; Shirai J; Yamamoto S
    Bioorg Med Chem; 2018 Feb; 26(3):721-736. PubMed ID: 29342416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
    Mitro N; Vargas L; Romeo R; Koder A; Saez E
    FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The medicinal chemistry of liver X receptor (LXR) modulators.
    Tice CM; Noto PB; Fan KY; Zhuang L; Lala DS; Singh SB
    J Med Chem; 2014 Sep; 57(17):7182-205. PubMed ID: 24832115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cardenolides strophanthidin, digoxigenin and dihydroouabain act as activators of the human RORγ/RORγT receptors.
    Karaś K; Sałkowska A; Walczak-Drzewiecka A; Ryba K; Dastych J; Bachorz RA; Ratajewski M
    Toxicol Lett; 2018 Oct; 295():314-324. PubMed ID: 29981919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfoximines as potent RORγ inverse agonists.
    Ouvry G; Bihl F; Bouix-Peter C; Christin O; Defoin-Platel C; Deret S; Feret C; Froude D; Hacini-Rachinel F; Harris CS; Hervouet C; Lafitte G; Luzy AP; Musicki B; Orfila D; Parnet V; Pascau C; Pascau J; Pierre R; Raffin C; Rossio P; Spiesse D; Taquet N; Thoreau E; Vatinel R; Vial E; Hennequin LF
    Bioorg Med Chem Lett; 2018 May; 28(8):1269-1273. PubMed ID: 29571573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.
    Kumar N; Solt LA; Conkright JJ; Wang Y; Istrate MA; Busby SA; Garcia-Ordonez RD; Burris TP; Griffin PR
    Mol Pharmacol; 2010 Feb; 77(2):228-36. PubMed ID: 19887649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt.
    Kummer DA; Cummings MD; Abad M; Barbay J; Castro G; Wolin R; Kreutter KD; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Urbanski M; Venkatesan H; Wang A; Woods C; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 May; 27(9):2047-2057. PubMed ID: 28318945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist Screening.
    Koyama R; Fukuda Y; Kamada Y; Nakagawa H; Witmer D; Ambrus-Aikelin G; Sang BC; Nakayama M; Iwata H
    Assay Drug Dev Technol; 2018; 16(4):194-204. PubMed ID: 29874096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses.
    Pandya VB; Kumar S; Sachchidanand ; Sharma R; Desai RC
    J Med Chem; 2018 Dec; 61(24):10976-10995. PubMed ID: 30010338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors.
    Li X; Anderson M; Collin D; Muegge I; Wan J; Brennan D; Kugler S; Terenzio D; Kennedy C; Lin S; Labadia ME; Cook B; Hughes R; Farrow NA
    J Biol Chem; 2017 Jul; 292(28):11618-11630. PubMed ID: 28546429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists.
    Marcoux D; Bertrand MB; Weigelt CA; Yip S; Galella M; Park H; Wu DR; Wang J; Yarde M; Cvijic ME; Li S; Hynes J; Tino JA; Zhao Q; Dhar TGM
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127466. PubMed ID: 32763309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining Target Engagement Required for Efficacy
    Lugar CW; Clarke CA; Morphy R; Rudyk H; Sapmaz S; Stites RE; Vaught GM; Furness K; Broughton HB; Durst GL; Clawson DK; Stout SL; Guo SY; Durbin JD; Stayrook KR; Edmondson DD; Kikly K; New NE; Bina HA; Chambers MG; Shetler P; Chang WY; Chang VC; Barr R; Gough WH; Steele JP; Getman B; Patel N; Mathes BM; Richardson TI
    J Med Chem; 2021 May; 64(9):5470-5484. PubMed ID: 33852312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RORγ antagonists and inverse agonists: a patent review.
    Bronner SM; Zbieg JR; Crawford JJ
    Expert Opin Ther Pat; 2017 Jan; 27(1):101-112. PubMed ID: 27629281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.